Insulin levels and HOMA index are associated with exercise capacity in patients with type 2 diabetes and coronary artery disease

Diabetology and Metabolic Syndrome

Volumn 6, Issue 1, 2014, Pages

  Byrkjeland, Rune ^a,b,c   Edvardsen, Elisabeth ^a,d   Njerve, Ida Unhammer ^a,b,c   Arnesen, Harald ^a,b,c   Seljeflot, Ingebjørg ^a,b,c   Solheim, Svein ^a,b  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

^d NORWEGIAN SCHOOL OF SPORT SCIENCES   (Norway)

Author keywords

Coronary artery disease; HOMA index; Insulin resistance; Type 2 diabetes

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN;

ADULT; ARTICLE; CARDIOPULMONARY EXERCISE TEST; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORRELATION ANALYSIS; DYSPNEA; EXERCISE; EXERCISE INDUCED ISCHEMIA; FEMALE; HOMEOSTATIC MODEL ASSESSMENT; HUMAN; INSULIN RESISTANCE; ISCHEMIA; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; OXYGEN CONSUMPTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK; THORAX PAIN; TREADMILL EXERCISE;

EID: 84899110505     PISSN: None     EISSN: 17585996     Source Type: Journal    
DOI: 10.1186/1758-5996-6-36     Document Type: Article

References (34)

1. Low cardiorespiratory fitness and physical inactivity as predictors of mortality in men with type 2 diabetes. Wei M, Gibbons LW, Kampert JB, Nichaman MZ, Blair SN, Ann Intern Med 2000 132 605 611 10766678
2. Peak aerobic capacity predicts prognosis in patients with coronary heart disease. Keteyian SJ, Brawner CA, Savage PD, Ehrman JK, Schairer J, Divine G, Aldred H, Ophaug K, Ades PA, Am Heart J 2008 156 292 300 10.1016/j.ahj.2008.03. 017 18657659
3. Physical fitness as a predictor of mortality among healthy, middle-aged Norwegian men. Sandvik L, Erikssen J, Thaulow E, Erikssen G, Mundal R, Rodahl K, N Engl J Med 1993 328 533 537 10.1056/NEJM199302253280803 8426620
4. Ten-year experience with an exercise-based outpatient life-style modification program in the treatment of diabetes mellitus. Schneider SH, Khachadurian AK, Amorosa LF, Clemow L, Ruderman NB, Diabetes Care 1992 15 1800 1810 10.2337/diacare.15.11.1800 1468318
5. Effects of non-insulin-dependent diabetes on oxygen consumption during treadmill exercise. Regensteiner JG, Sippel J, McFarling ET, Wolfel EE, Hiatt WR, Med Sci Sports Exerc 1995 27 875 881 7658949
6. Cardiac dysfunction during exercise in uncomplicated type 2 diabetes. Regensteiner JG, Bauer TA, Reusch JE, Quaife RA, Chen MY, Smith SC, Miller TM, Groves BM, Wolfel EE, Med Sci Sports Exerc 2009 41 977 984 10.1249/MSS. 0b013e3181942051 19346991
7. Skeletal muscle deoxygenation after the onset of moderate exercise suggests slowed microvascular blood flow kinetics in type 2 diabetes. Bauer TA, Reusch JE, Levi M, Regensteiner JG, Diabetes Care 2007 30 2880 2885 10.2337/dc07-0843 17675540
8. Wasserman K, Hansen JE, Sue DY, Stringer WW, Whipp BJ, Principles of execise testing and interpretation including pathophysiology and clinical applications Philadelphia: Lippincott Williams & Wilkins 2005
9. Impact of diabetes, chronic heart failure, congenital heart disease and chronic obstructive pulmonary disease on acute and chronic exercise responses. Brassard P, Ferland A, Marquis K, Maltais F, Jobin J, Poirier P, Can J Cardiol 2007 23 Suppl B 89B 96B 17932595
10. Determinants of exercise capacity in patients with type 2 diabetes. Fang ZY, Sharman J, Prins JB, Marwick TH, Diabetes Care 2005 28 1643 1648 10.2337/diacare.28.7.1643 15983314
11. Type 2 diabetes mellitus and exercise impairment. Reusch JE, Bridenstine M, Regensteiner JG, Rev Endocr Metab Disord 2013 14 77 86 10.1007/s11154-012- 9234-4 23299658
12. Insulin resistance and maximal oxygen uptake. Seibaek M, Vestergaard H, Burchardt H, Sloth C, Torp-Pedersen C, Nielsen SL, Hildebrandt P, Pedersen O, Clin Cardiol 2003 26 515 520 10.1002/clc.4960261107 14640466
13. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Wild S, Roglic G, Green A, Sicree R, King H, Diabetes Care 2004 27 1047 1053 10.2337/diacare.27.5.1047 15111519
14. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Ryden L, Standl E, Bartnik M, Van den Berghe G, Betteridge J, de Boer MJ, Cosentino F, Jonsson B, Laakso M, Malmberg K, Priori S, Ostergren J, Tuomilehto J, Thrainsdottir I, Vanhorebeek I, Stramba-Badiale M, Lindgren P, Qiao Q, Priori SG, Blanc JJ, Budaj A, Camm J, Dean V, Deckers J, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, et al. Eur Heart J 2007 28 88 136 17220161
15. Silent myocardial ischemia in patients with diabetes: who to screen. Janand-Delenne B, Savin B, Habib G, Bory M, Vague P, Lassmann-Vague V, Diabetes Care 1999 22 1396 1400 10.2337/diacare.22.9.1396 10480499
16. Cardiovascular manifestations of insulin resistance. Chahwala V, Arora R, Am J Ther 2009 16 14 e28 10.1097/MJT.0b013e3180a724b3 19114874
17. Exercise standards for testing and training: a statement for healthcare professionals from the American Heart Association. Fletcher GF, Balady GJ, Amsterdam EA, Chaitman B, Eckel R, Fleg J, Froelicher VF, Leon AS, Pina IL, Rodney R, Simons-Morton DA, Williams MA, Bazzarre T, Circulation 2001 104 1694 1740 10.1161/hc3901.095960 11581152
18. An experimental study of physical fitness of Air Force personnel. Balke B, WARE RW, U S Armed Forces Med J 1959 10 675 688 13659732
19. Perceived exertion. Borg GA, Exerc Sport Sci Rev 1974 2 131 153 4466663
20. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC, Diabetologia 1985 28 412 419 10.1007/BF00280883 3899825
21. HOMA2 Score Calculator Web site, Oxford, UK, diabetes trial unit, the Oxford centre for diabetes, endocrinology and metabolism. 1-5-2013 2012 http://www.dtu.ox.ac.uk/homacalculator/index.php
22. Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Levy JC, Matthews DR, Hermans MP, Diabetes Care 1998 21 2191 2192 10.2337/diacare.21.12.2191 9839117
23. Use and abuse of HOMA modeling. Wallace TM, Levy JC, Matthews DR, Diabetes Care 2004 27 1487 1495 10.2337/diacare.27.6.1487 15161807
24. Metabolic syndrome: definitions and controversies. Kassi E, Pervanidou P, Kaltsas G, Chrousos G, BMC Med 2011 9 48 10.1186/1741-7015-9-48 21542944
25. Insulin resistance in relatives of NIDDM patients: the role of physical fitness and muscle metabolism. Nyholm B, Mengel A, Nielsen S, Skjaerbaek C, Moller N, Alberti KG, Schmitz O, Diabetologia 1996 39 813 822 10.1007/s001250050515 8817106
26. Rosiglitazone improves exercise capacity in individuals with type 2 diabetes. Regensteiner JG, Bauer TA, Reusch JE, Diabetes Care 2005 28 2877 2883 10.2337/diacare.28.12.2877 16306548
27. Diabetic cardiomyopathy revisited. Boudina S, Abel ED, Circulation 2007 115 3213 3223 10.1161/CIRCULATIONAHA.106.679597 17592090
28. Muscle mitochondria and insulin resistance: a human perspective. Hoeks J, Schrauwen P, Trends Endocrinol Metab 2012 23 444 450 10.1016/j.tem.2012.05.007 22726362
29. Insulin resistance and the endothelium. Hsueh WA, Lyon CJ, Quinones MJ, Am J Med 2004 117 109 117 10.1016/j.amjmed.2004.02.042 15234647
30. Effects of insulin resistance on endothelial function: possible mechanisms and clinical implications. Tousoulis D, Tsarpalis K, Cokkinos D, Stefanadis C, Diabetes Obes Metab 2008 10 834 842 10.1111/j.1463-1326.2007. 00818.x 18034844
31. Peripheral vascular endothelial function testing as a noninvasive indicator of coronary artery disease. Kuvin JT, Patel AR, Sliney KA, Pandian NG, Rand WM, Udelson JE, Karas RH, J Am Coll Cardiol 2001 38 1843 1849 10.1016/S0735-1097(01)01657-6 11738283
32. Metabolic syndrome and insulin resistance: underlying causes and modification by exercise training. Roberts CK, Hevener AL, Barnard RJ, Compr Physiol 2013 3 1 58 23720280
33. Studies on the mechanism of improved glucose control during regular exercise in type 2 (non-insulin-dependent) diabetes. Schneider SH, Amorosa LF, Khachadurian AK, Ruderman NB, Diabetologia 1984 26 355 360 6376244
34. Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage. Muniyappa R, Lee S, Chen H, Quon MJ, Am J Physiol Endocrinol Metab 2008 294 15 E26 17957034